Search
Enanta Pharmaceuticals Inc
ENTAAdd to Watchlist
12.300USD
-0.220-1.76%
Market hours 09/18, 15:50（ET）
358.18MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-1.76%
5 Days
-3.15%
1 Month
-4.13%
6 Months
-7.31%
Year to Date
-22.00%
1 Year
+63.13%
Key Figures
12.605Open
12.575High
11.19KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.04%Turnover Ratio
12.520Prev. Close
12.225Low
138.20KTurnover
LossP/E Static
3.54P/B
0.00%Div Yield TTM
-19.44%ROA
17.15052wk High
0.04Volume Ratio
-81.89MNet Profit
29.12MShares
-2.5943EPS TTM
0.99Beta
-59.00%ROE
7.05052wk Low
2.80%Amplitude
100.00%Gross Margin
358.18MMarket Cap
--Reward/Risk
6.77%Risk Rate
Enanta Pharmaceuticals Inc's Score
0.06vs previous score
Forecast8.67
Financial Health7.12
Technical4.22
Valuation Dimensions7.38
Institutional Confidence10.00
Risk Assessment5.76
Media Coverage
Coverage Level
Very Low
Very High
Positive
Analyst Rating
Enanta Pharmaceuticals Inc Technical Analysis
Technical Indicators
Strong sell
Summary
Sell
Moving Average
Strong sell
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
-0.67/-0.51
Revenue / Forecast
14.36M/16.80M
Enanta Pharmaceuticals Inc Profile
SectorPharmaceuticals
Ticker SymbolENTA
Number of employees120
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Janus Henderson Investors | 12.85% |
| Farallon Capital Management, L.L.C. | 9.55% |
| Krensavage Asset Management, LLC | 9.53% |
| BlackRock Institutional Trust Company, N.A. | 7.18% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 32.07% |
| Investment Advisor/Hedge Fund | 31.53% |
| Hedge Fund | 26.12% |
| Individual Investor | 4.87% |
Related Instruments
+0.17%
+0.55%
+0.20%
+0.25%
+0.06%
-0.32%
+1.58%
-0.19%
-0.27%
+0.39%
-1.27%
-0.51%
-1.68%
-1.32%
-0.61%
-0.50%
-0.01%
-1.87%
-0.47%
-0.34%Popular Instruments
51715.900
-44.100 (-0.09%)
29584.500
+171.800 (+0.58%)
7646.300
+14.200 (+0.19%)
14409.000
+108.000 (+0.76%)
65103.000
+154.000 (+0.24%)
6230.700
-76.500 (-1.21%)
96.231
-1.755 (-1.79%)
336.700
-0.300 (-0.09%)
219.890
+0.550 (+0.25%)
4381.850
+40.870 (+0.94%)
FAQs
What is the current price of Enanta Pharmaceuticals Inc (ENTA)?
The current price of Enanta Pharmaceuticals Inc (ENTA) is 12.52.
What is the symbol of Enanta Pharmaceuticals Inc?
The ticker symbol of Enanta Pharmaceuticals Inc is ENTA.
What is the 52-week high of Enanta Pharmaceuticals Inc?
The 52-week high of Enanta Pharmaceuticals Inc is 17.15.
What is the 52-week low of Enanta Pharmaceuticals Inc?
The 52-week low of Enanta Pharmaceuticals Inc is 7.05.
What is the market capitalization of Enanta Pharmaceuticals Inc?
The market capitalization of Enanta Pharmaceuticals Inc is 364.29M.
Is Enanta Pharmaceuticals Inc (ENTA) currently rated as Buy, Hold, or Sell?
According to analysts, Enanta Pharmaceuticals Inc (ENTA) has an overall rating of Buy, with a price target of 22.40.
What is the Earnings Per Share (EPS TTM) of Enanta Pharmaceuticals Inc (ENTA)?
The Earnings Per Share (EPS TTM) of Enanta Pharmaceuticals Inc (ENTA) is -2.59.